No picture yet
Rinvoq 45 mg – DIN 02539721
Rinvoq is Upadacitinib 45 mg (tablet (extended-release)), sold in Canada. It is supplied by Abbvie Corporation. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Upadacitinib 45 mg
- Brand
- Rinvoq
- Strength
- 45 mg
- Form
- Tablet (extended-release)
- Manufacturer
- Abbvie Corporation
- Sold in
- Canada
- DIN
- 02539721
Is this your medicine? Check the box
- The box or bottle shows DIN 02539721.
- It names Rinvoq, Upadacitinib 45 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Rinvoq by Abbvie Corporation.
In Canada: prescription only.
Ingredients
Active: Upadacitinib
Other Upadacitinib pills
- a15 Upadacitinib 15 mg Purple, oval, 14 mm
- a30 Upadacitinib 30 mg Red, oval, 14 mm
- a45 Upadacitinib 45 mg Yellow, oval, 14 mm
- No picture yet DIN 02495155 Upadacitinib 15 mg Rinvoq, Tablet (extended-release), sold in Canada
- No picture yet DIN 02520893 Upadacitinib 30 mg Rinvoq, Tablet (extended-release), sold in Canada